drugset / Trial / NCT00421538

Randomized Controlled Trial of Anticoagulation vs. Placebo for a First Symptomatic Isolated Distal Deep-vein Thrombosis (IDDVT)

NCT00421538

RandomizedParallel-groupQuadruple-blindTreatment

Summary

CACTUS-PTS is a randomized, placebo-controlled, double-blind study which aims primarily to determine the effectiveness of a 6 week course of therapeutic-dose LMWH (nadroparine) injections vs. placebo in patients with a first symptomatic isolated distal (calf) deep-vein thrombosis (IDDVT), as measured by rate of proximal DVT and symptomatic PE at 6 weeks. Additionally, the study aims to determine if the 6 week course of treatment with therapeutic-dose LMWH (nadroparine) injections, compared to placebo, decreases the frequency of post-thrombotic syndrome (PTS) at 1 year.

Timeline

Start
2008-01
Primary completion
2015-05
Completion
2015-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dalteparin sodium Other / unclassified 171 iu/kg Subcutaneous